Details for New Drug Application (NDA): 209564
✉ Email this page to a colleague
The generic ingredient in LINACLOTIDE is linaclotide. There are ten drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the linaclotide profile page.
Summary for 209564
Tradename: | LINACLOTIDE |
Applicant: | Mylan |
Ingredient: | linaclotide |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 145MCG | ||||
Approval Date: | Feb 9, 2021 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 290MCG | ||||
Approval Date: | Feb 9, 2021 | TE: | RLD: | No |
Complete Access Available with Subscription